tripLet, bS; nathan everDing, MD Management of an infected shoulder arthroplasty remains challenging. Treatment goals include resolution of the infection, improvement in pain, and restoration of function. Two-stage revision with an antibiotic spacer and subsequent revision has shown variable success in achieving these goals. The practice of using a hemiarthroplasty and coating the stem with antibiotic cement without cementing the implant to the humerus (functional antibiotic spacer) during the first stage has the potential to achieve treatment goals without the need for a second revision. The goal of this study was to examine the outcomes of a maintained functional antibiotic spacer without a second revision for the management of infected shoulder arthroplasty. Fourteen patients with an infected shoulder arthroplasty underwent implantation of a functional antibiotic spacer, extensive surgical debridement, and a minimum of 6 weeks of treatment with postoperative intravenous antibiotics. The 9 patients who elected not to undergo revision surgery were included in this analysis. Pain scores, functional outcome scores, range of motion, strength, and patient satisfaction were measured for these patients at last follow-up and compared with preoperative scores. At an average follow-up of 25 months (range, 12-48 months), significant improvements were observed in functional outcome scores, shoulder abduction, and elevation, with a trend toward improvement in pain scores. One patient was unsatisfied with the result. No recurrent infection, progressive radiolucency, or change in position of the functional antibiotic spacer was observed. A functional antibiotic spacer effectively manages the infected shoulder arthroplasty while achieving significant improvements in function and motion. Patient satisfaction was high, with a relatively low rate of conversion to second-stage revision.
M
anagement of an infected shoulder arthroplasty remains a challenge. Infection rates after shoulder arthroplasty have a reported incidence of up to 4% for primary shoulder arthroplasty and up to 15.4% for revision arthroplasty. [1] [2] [3] [4] [5] There are limited reliable preoperative and intraoperative tests that predict which patients will have positive intraoperative culture findings at the time of revision surgery. 6 However, once infection is identified, management of the infection while maintaining pain relief and function can be difficult.
Several treatment options are available for patients identified with or suspected of having an infection, with the common primary goal of its resolution. Pain relief and maintenance of adequate function are secondary goals that often are not achieved. 3, 4, [7] [8] [9] Historically, treatment modalities have included antibiotic therapy alone, debridement with retention of the prosthesis, single-stage revision, 2-stage revision, and resection arthroplasty. 1, 3, 10 Several series have reported results with each of these treatments, but no definitive standard of care has been established for treating patients with an infected shoulder arthroplasty.
3 A 2-stage revision is often used in accordance with recommendations for infected total knee or hip arthroplasty. 3 During 2-stage revision, antibiotic cement spacers are used both for local delivery of antibiotics and to maintain a soft tissue envelope and prevent significant contractures. Stine et al 11 noted cases where medical comorbidities, advanced age, or very low functional demands led patients to maintain the antibiotic cement spacer without a subsequent second-stage revision. Functional outcome and motion were not significantly different than those in patients treated with second-stage revision. 11, 12 It is possible, however, that patients may be unable to tolerate the spacer as a definitive hemiarthroplasty because of frictional pain at the glenohumeral joint or because of lack of motion. Additionally, the long-term effects that cement may have on the glenoid have not been investigated and may result in glenoid bone erosion and pain.
With these challenges in mind, the concept of a functional antibiotic spacer was introduced. The functional antibiotic spacer uses a small humeral stem coated with a thick layer of antibiotic-loaded cement, leaving a cobalt-chrome humeral head of appropriate size without cement coverage. The cement is allowed to cure before it adheres to the humerus, creating a loose but stable fit that matches but does not bind to the intricacies of the proximal humerus geometry. Use of this functional antibiotic spacer is a novel technique improving on the previous principles of antibiotic spacers. This technique maintains a soft tissue envelope with appropriate tension to assist in subsequent revision surgery and allows for antibiotic elution. In addition, the cement-bone articulation is substituted with a metal-bone articulation, as in hemiarthroplasty, which potentially helps to improve function and decrease pain during the period of treatment before second-stage revision. To the authors' knowledge, the use of a hemiarthroplasty with an antibiotic-coated stem (functional spacer) for the management of an infected shoulder arthroplasty has not been reported. In using this technique, most patients declined further revision surgery because they had acceptable function and pain levels with this functional antibiotic spacer technique. The goal of this study was to examine the outcomes of a maintained functional antibiotic spacer without a second revision for the management of infected shoulder arthroplasty. The authors' hypothesis was that patients who were treated with a functional antibiotic spacer could achieve low rates of recurrent infection and conversion to a secondstage revision, with improvements in pain, range of motion, functional outcomes, and patient satisfaction.
Materials and Methods
From September 2007 to February 2013, 14 patients underwent planned 2-stage revision for a known infected shoulder arthroplasty using a functional spacer, extensive surgical debridement, and a minimum of 6 weeks of treatment with postoperative intravenous antibiotics managed by an infectious disease specialist. Antibiotic administration was stopped by the infectious disease specialist when it was determined that patients were clear of infection and had normal laboratory values. Although second-stage revision was always offered after resolution of infection, patients were told that a second stage was not obligatory if they obtained acceptable pain relief and function without signs of recurrent infection. A retrospective review of prospectively collected data for these patients was performed. Of the 14 patients, 9 refused a second-stage procedure and maintained the functional spacer as the definitive shoulder arthroplasty. This group served as the cohort of interest. The average age of patients with a maintained functional spacer was 72.3 years (range, 62-80 years). There were 6 men and 3 women.
Five patients elected to undergo a second-stage procedure because of unacceptable pain and poor function. Three patients had rotator cuff deficiency and underwent revision to a reverse shoulder arthroplasty. One underwent revision to a total shoulder arthroplasty, and the remaining patient underwent revision to another functional spacer based on intraoperative frozen section findings during the second-stage surgery. During all 5 revision procedures, removal of the functional spacer was quick and simple because there was no cement bond between the implant and the humeral canal. Mean time to the second-stage revision was 5.6 months (range, 4-10 months). Mean age of the patients who underwent the secondstage procedure was 59.3 years, with 3 of these patients younger than 52 years. At the time of the second surgery, only 1 patient had acute inflammation intraoperatively and on the final pathology report. All 5 patients had multiple negative culture findings (minimum, 4) and normal preoperative laboratory values.
Because of the retrospective nature of the study, the institutional review board determined that this study met the conditions for exemption under Part 46 of Title 45 of the Code of Federal Regulations (45 CFR 46). Thus, no informed consent was necessary.
Preoperative Workup
All 14 patients had signs of an infection, based on clinical evaluation, radiographs, and laboratory test results ( Table  1) . Radiographs were examined for signs of loosening of the humeral and glenoid components (when present). Humeral loosening was defined as a radiolucent line 2 mm or greater in width that was present in 3 or more zones for the humeral stem (based on the 8-zone classification). 13, 14 In cases of total shoulder arthroplasty, glenoid loosening was defined as grade 5 changes based on the classification of Lazarus et al. 15 Ten patients showed evidence of radiographic loosening on preoperative radiographs (Figure 1) . Three patients presented with actively draining wounds. Of the 13 patients with obtainable preoperative laboratory values, 4 had normal values for leukocyte count, erythrocyte sedimentation rate, and C-reactive protein level. Only 5 patients had elevation of both erythrocyte sedimentation rate and C-reactive protein level. Three patients had a preoperative technetium bone scan, with only 1 showing increased uptake around the arthroplasty, suggestive of infection.
Intraoperative Findings
All but 1 patient had positive intraoperative culture findings at the time of the first-stage procedure or from a previous arthroscopic biopsy (2 patients). Three patients had polymicrobial infections. Propionibacterium acnes was the most common bacteria identified in culture and was seen in 50% of patients (7 of 14 patients). Frozen section examination showed acute inflammation (>5 polymorphonuclear leukocytes/high-power field) 16 in all patients. One patient had incomplete removal of a well-fixed cement mantle that extended to the midshaft humerus during first-stage surgery and did not undergo a second revision.
Functional Spacer Technique
After removal of all previously implanted components and extensive surgical debridement, with removal of all possibly infected and inflammatory tissue, a functional spacer was fashioned. The functional spacer consisted of a size 6 Foundation humeral hemiarthroplasty stem (Encore, Austin, Texas) coated with antibiotic cement and a Foundation humeral head of appropriate size and void of cement. For the antibiotic cement, a single dose of Symplex P with tobramycin (Stryker, Kalamazoo, Michigan) was combined with an additional 3 g of vancomycin and 2.2 g of tobramycin and manually molded around the stem (Figure 2) . As the cement began to cure and the consistency became firm, but still moldable, the spacer was placed into the humeral canal. It was allowed to mold to the intricacies of the metaphyseal bone and was then quickly removed. This process was repeated until the cement completely cured. The functional spacer was then implanted back into the humeral canal, creating a snug fit that did not bind to the humerus (Figure 3) . The stem fit should be tight enough to prevent gross stem motion with rotation of the glenohumeral joint, but loose enough to allow removal with limited force. Because the cement is not bound to the humerus, this technique allows for easier implant removal during the planned second-stage revision. Unlike a definitive single-stage revision, not all pathology was corrected during this debridement and spacer implantation. Most patients had rotator cuff deficiency or glenoid pathology that would have been addressed with a reverse or total shoulder arthroplasty as opposed to hemiarthroplasty as a definitive procedure.
Outcomes Measured
Clinical outcomes were evaluated for each patient before the first-stage procedure and at the most recent follow-up. Clinical outcome measures included range of motion as measured with a goniometer, manual muscle strength (range, 0-5), American Shoulder and Elbow Surgeons score, Simple Shoulder Test score, Single Assessment Numeric Evaluation, visual analog scale function score, visual analog scale pain score, 12-Item Short Form Health Survey, and patient subjective satisfaction (excellent, good, satisfied, or unsatisfied) score.
Radiographic Analysis
The most recent anteroposterior and axillary radiographs were compared with similar radiographs taken immediately after the first-stage procedure. Radiographs were examined for signs of loosening, defined as a progressive radiolucent line 2 mm or greater in width present in 3 or more zones (based on the 8-zone classification), 13, 14 and change in implant position.
Postoperative Therapy Program
After surgery, patients were placed into a shoulder immobilizer and instructed on performing pendulum exercises 3 times daily. Patients were maintained in an immobilizer for 6 weeks. When the immobilizer was discontinued, patients were instructed to perform supine stretching and were allowed to resume activities of daily living with a 2-pound weight restriction. At 12 weeks postoperatively, patients were allowed to resume activity without restriction.
Statistical Analysis
Wilcoxon signed-rank test (nonparametric) was performed to assess preoperative and postoperative differences among outcome measures. These variables included functional outcomes (Simple Table 1 Preoperative and Intraoperative Evaluations of Infected Shoulder Arthroplasty Table 2) .
results
Average follow-up for the 9 patients with a maintained functional spacer was 25 months (range, 12-48 months). A summary of preoperative and postoperative outcome scores is shown in Table 2 . Statistically significant improvements were observed for American Shoulder and Elbow Surgeons score (preoperative mean=31.3 and postoperative mean=65.8; P=.031) and Single Assessment Numeric Evaluation score (preoperative mean=17.2 and postoperative mean=54.6; P=.031). Forward elevation and abduction motion were also significantly improved from preoperatively to postoperatively (P=.012 and P=.043, respectively; Table  2 ). At the most recent follow-up, average forward elevation was 90° (range, 40°-145°) and average abduction was 70° (range, 50°-95°). Although it was not statistically significant, a clinically relevant improvement was noted in visual analog scale pain score (5.7-2.0, P=.063). No statistically significant improvements were seen in postoperative strength. Subjectively, 89% of patients were satisfied with the outcome, with 4 reporting excellent, 1 reporting good, and 3 reporting satisfactory results. Only 1 patient was unsatisfied with the result.
At the most recent follow-up, no patient had clinical or radiographic signs suggesting recurrent infection. Radiographs did not show progressive radiolucent lines or change in the position of the functional spacer. No patient was given long-term suppression therapy.
discussion
Early results indicated that the use of a functional antibiotic spacer during firststage management of infected shoulder arthroplasty has the potential to achieve treatment goals without the need for a second-stage revision. Second-stage revisions were requested in only 36% of cases. When the functional spacer was used as a definitive implant, patients had statistically significant improvements in functional outcomes and range of motion. A clinically important but nonsignificant improvement was noted in visual analog scale pain scores with the maintained functional spacer. This lack of significance is likely related to the small number of patients. Furthermore, patient satisfaction was high (89%), and no patient treated with this technique had a recurrent infection, including those who 
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elected to proceed with a second-stage procedure. Two-stage revision surgery is often advocated for use in infected shoulder arthroplasty. Two-stage revisions have been shown to be effective in resolving infection; however, their effect on functional outcomes has been variable. 3, 4, [7] [8] [9] Strickland et al 17 reported high rates of unsatisfactory results (68%) and a high complication rate after 2-stage reimplantation. Hattrup and Renfree 8 showed that 2-stage revision surgery was successful in reducing pain and resolving the underlying infection; however, functional outcome scores (Simple Shoulder Test score, American Shoulder and Elbow Surgeons score) were not significantly improved.
An alternative option for managing infected shoulder arthroplasty is resection arthroplasty. Muh et al 10 reported significant improvements in pain but poor motion and functional outcomes after resection arthroplasty.
The major advantage of the functional antibiotic spacer is avoidance of the morbidity and associated costs of an often challenging second-stage surgical procedure. Associated technical challenges of second-stage revision surgery that can be avoided by using the functional antibiotic spacer include soft tissue contractions, humeral bone loss caused by spacer micromotion, glenoid bone loss from cement articulation, and intra-articular scar tissue. Each of these challenges may severely compromise the functional result of second-stage revision surgery and may be circumvented with the use of a functional antibiotic spacer.
Although placing exposed metal hardware into a recently contaminated joint is controversial, studies have shown successful outcomes with single-stage revision of infected primary and reverse shoulder arthroplasty without recurrence of infection. [18] [19] [20] In the current series, infection was effectively controlled in all 14 patients. Both the traditional spacer and the functional spacer allow the surgeon to mix antibiotics into the cement, permitting local delivery of high doses of appropriate antibiotics to help resolve the infection. The functional spacer avoids persistent articulation of cement with the glenoid, although the long-term effects are unstudied. Additionally, use of a metal bearing surface allows debridement and reaming of the glenoid face to be performed without concern about the effects of a cement-bearing surface on a prepared glenoid bone surface.
Several studies showed patients' refusal to proceed to second-stage revision and decision to retain a traditional antibiotic spacer as a definitive implant. Coffey et al 6 reported 4 cases in which a commercially available cement spacer was used as the definitive shoulder hemiarthroplasty because patients deferred additional surgery as a result of satisfactory outcomes. Stine et al 11 reported a series of patients with maintained traditional antibiotic cement spacers for management of a variety of postoperative (including arthroplasty) shoulder infections. Although they reported no significant difference in motion and functional outcomes between patients with a maintained traditional spacer (15 patients) and those who underwent a second-stage procedure (15 patients), no comparison with preoperative status was performed to establish the efficacy of treatment. 11 The current results showed 23 preoperative laboratory results were unreliable in predicting infection. In this study, 4 patients (31%) had normal values for leukocyte count, erythrocyte sedimentation rate, and C-reactive protein level. The C-reactive protein level was elevated in 8 of 13 patients (62%), and the erythrocyte sedimentation rate was elevated in 6 of 13 patients (46%). Both recent literature and this study showed that serum leukocyte count is not a reliable marker of an infected shoulder arthroplasty. 8 An effectively managed infection, achievement of acceptable outcomes, and potential cost savings as a result of averting a second surgery provide a solid rationale for using a functional spacer during the initial stage of planned 2-stage management of an infected shoulder arthroplasty. A more detailed investigation of the costbenefit analysis of this technique is warranted. The functional spacer may be more costly than a traditional handmade spacer used in a typical 2-stage revision surgery. However, its use as a definitive implant could result in significant overall savings because the associated costs of a second surgery would likely exceed the additional cost of the functional spacer. No recurrent infections were reported in this series, and the cost of recurrent infection could significantly affect the cost-benefit ratio.
Limitations
This study had several limitations. The average follow-up was 25 months, and longer follow-up could result in different outcomes or the need for additional revisions. The functional spacer technique involves placement of a cement-covered stem without allowing the stem to bond to the humeral canal. Thus, the stem is intentionally placed loosely. This placement could potentially lead to humeral loosening at longer follow-up intervals. Additionally, articulation of a metallic head on the native glenoid may lead to progressive glenoid wear. Over time, this may result in increased pain and worsening function, along with further glenoid bone loss, making future revisions more challenging. This concern is greater in younger patients because the cumulative risk of glenoid wear increases with time and justifies close observation. It is important to counsel patients and inform them that second-stage revision is an option in the event of declining quality of life secondary to unmanageable pain and loss of function. Additionally, the small sample size may affect the significance of improvement in the assessed variables. Although trends toward improvement were seen for certain variables, such as visual analog scale pain score, 12-Item Short Form Health Survey (physical health component summary) score, and Simple Shoulder Test score, they were not statistically significant. A larger series may provide a more accurate assessment of outcomes. Because this study was a case series, comparisons between a functional spacer and 2-stage revision surgery were not possible. Therefore, a randomized control trial with repeated measures over a significant period comparing 2-stage revision surgery and use of a functional spacer is needed. Finally, with only 1 infection as a result of Staphylococcus aureus, selection bias related to bacterial infections may have influenced the infection recurrence rates seen in this study. Nearly all infections in this study were related to low-virulence organisms, such as P acnes.
conclusion
Early results indicated that placement of a functional antibiotic spacer assists in the effective management of postarthroplasty infection, has a relatively low rate of conversion to a second-stage procedure, and results in significant improvements in function and motion, with high levels of patient satisfaction. This technique merits further attention when managing infected shoulder arthroplasty.
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